GSK163929
GSK163929 is an orally bioavailable CCR5 antagonist developed for HIV research, exhibiting anti-HIV activity with low hERG channel inhibition. It has demonstrated a favorable safety profile in rodent and canine in vivo toxicity studies at specified intravenous doses, supporting its investigation as a potential therapeutic agent.
Product Specifications
CAS Number
716354-04-0
Field of Research
Immunology & Inflammation, Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Smiles
C (CN1[C@@]2 (C[C@H] (C[C@]1 (CC2) [H]) N3C=4C (N=C3C) =CC=CC4) [H]) C5 (CCN (C (=O) C6=CC (S (NC) (=O) =O) =C (F) C=C6Cl) CC5) C7=CC (F) =CC=C7
Molecular Formula
C36H40ClF2N5O3S
Molecular Weight
696.25
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx256007-01 96 Tests
Rat Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) ELISA Kit
Sign In for Pricing
View Details 
abx256007-02 5x 96 Tests
Rat Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) ELISA Kit
Sign In for Pricing
View Details 
abx256007-03 10x 96 Tests
Rat Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) ELISA Kit
Sign In for Pricing
View Details